Department of Psychiatry and Psychotherapy, Heinrich Heine University, Düsseldorf
Department of Psychiatry II, University of Ulm, Germany
Department of Psychiatry, University of Geneva, Switzerland
Unit for Psychiatry and Health Promotion, Academic University Hospital, Uppsala, Sweden
Unity Health System, Department of Psychiatry and Behavioral Health, Rochester, New York, USA
Correspondence: Professor Wolfgang Gaebel, Department of Psychiatry and Psychotherapy, Heinrich Heine University Düsseldorf, Bergische Landstrasse 2, D-40629 Düsseldorf, Germany. E-mail: Wolfgang.Gaebel{at}uni-duesseldorf.de
Declaration of interest W.G. is one of the editors of the German schizophrenia guideline (from 1998); J.M. is the Chairman of the US Steering Committee on Practice Guidelines. Funding detailed in Acknowledgements.
Background Schizophrenia guidelines differ considerably in methodology and content.
Aims To systematically compare national schizophrenia guidelines from different countries.
Method An international survey was conducted on guideline development and a methodological comparison was made using a validated guideline appraisal instrument (the Appraisal Guideline Research and Evaluation Europe).
Results The methodological quality of many schizophrenia guidelines was at best moderate. Few guidelines had included key stakeholders in their development process. Although pharmacotherapy recommendations were similar, there were strong variations in the type of psychosocial interventions recommended.
Conclusions The methodological quality of guidelines has a strong influence on their applicability. However, the lack of financial means to develop and implement guidelines is a serious problem. Independent international organisations could contribute to defining a core set of unbiased schizophrenia treatmentrecommendations. In countries with a shortage of resources, this could be a basis for adaptation to different cultural and economic backgrounds in collaboration with stakeholders.
This article has been cited by other articles:
![]() |
W.L.D.M. Nelen, R.W. van der Pluijm, R.P.M.G. Hermens, C. Bergh, P. de Sutter, K.G. Nygren, A.M.M. Wetzels, R.P.T.M. Grol, and J.A.M. Kremer The methodological quality of clinical guidelines of the European Society of Human Reproduction and Embryology (ESHRE) Hum. Reprod., August 1, 2008; 23(8): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta and J. Warner A NICE mess J R Soc Med, October 1, 2007; 100(10): 442 - 443. [Full Text] [PDF] |
||||
![]() |
J. Chidgey, G. Leng, and T. Lacey Implementing NICE guidance J R Soc Med, October 1, 2007; 100(10): 448 - 452. [Full Text] [PDF] |
||||
![]() |
G. Leng, M. Rawlins, and M. Page Commentary: NICE--setting clinical standards BMJ, May 19, 2007; 334(7602): 1054 - 1055. [Full Text] [PDF] |
||||
![]() |
P. M. Haddad and S. Dursun Selecting antipsychotics in schizophrenia: lessons from CATIE J Psychopharmacol, May 1, 2006; 20(3): 332 - 334. [PDF] |
||||
![]() |
J. R. Bola Psychosocial Acute Treatment in Early-Episode Schizophrenia Disorders Research on Social Work Practice, May 1, 2006; 16(3): 263 - 275. [Abstract] [PDF] |
||||
![]() |
S. Leucht, M. Stiegler, C. Rummel, K. Wahlbeck, and W. Kissling Call for a European Guidelines Institute The British Journal of Psychiatry, February 1, 2006; 188(2): 193 - 193. [Full Text] [PDF] |
||||